115 related articles for article (PubMed ID: 12214265)
1. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs.
Blagosklonny MV
Oncogene; 2002 Sep; 21(41):6249-54. PubMed ID: 12214265
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M
Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.
Demidenko ZN; Kalurupalle S; Hanko C; Lim CU; Broude E; Blagosklonny MV
Oncogene; 2008 Jul; 27(32):4402-10. PubMed ID: 18469851
[TBL] [Abstract][Full Text] [Related]
6. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs.
Blagosklonny MV; Robey R; Bates S; Fojo T
J Clin Invest; 2000 Feb; 105(4):533-9. PubMed ID: 10683383
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
9. Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage.
Nehmé A; Lee BL; Baskaran R; Zhang Q; Lin X; Christen RD
Br J Cancer; 2000 Nov; 83(10):1360-6. PubMed ID: 11044362
[TBL] [Abstract][Full Text] [Related]
10. Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.
Blagosklonny MV; Bishop PC; Robey R; Fojo T; Bates SE
Cancer Res; 2000 Jul; 60(13):3425-8. PubMed ID: 10910051
[TBL] [Abstract][Full Text] [Related]
11. Vanadate induces G2/M phase arrest in p53-deficient mouse embryo fibroblasts.
Zhang Z; Chen F; Huang C; Shi X
J Environ Pathol Toxicol Oncol; 2002; 21(3):223-31. PubMed ID: 12435075
[TBL] [Abstract][Full Text] [Related]
12. Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.
Sugimoto K; Sasaki M; Isobe Y; Tsutsui M; Suto H; Ando J; Tamayose K; Ando M; Oshimi K
Oncogene; 2008 May; 27(22):3091-101. PubMed ID: 18071310
[TBL] [Abstract][Full Text] [Related]
13. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
Anderson HJ; Andersen RJ; Roberge M
Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
Dziadyk JM; Sui M; Zhu X; Fan W
Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
[TBL] [Abstract][Full Text] [Related]
16. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
[TBL] [Abstract][Full Text] [Related]
17. Flavopiridol inversely affects p21(WAF1/CIP1) and p53 and protects p21-sensitive cells from paclitaxel.
Blagosklonny MV; Darzynkiewicz Z; Figg WD
Cancer Biol Ther; 2002; 1(4):420-5. PubMed ID: 12432259
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.
Demidenko ZN; Vivo C; Halicka HD; Li CJ; Bhalla K; Broude EV; Blagosklonny MV
Cell Death Differ; 2006 Sep; 13(9):1434-41. PubMed ID: 16311509
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
20. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
